Cerevance
MA - Boston
BiotechnologyFocus: CNS small molecules
Cerevance is a life sciences company focused on CNS small molecules.
Neurology
Funding Stage
PUBLIC
Total Funding
$5M
Open Jobs
0
Products & Portfolio (1)
Pipeline & Clinical Trials
CVN766
Safety IssuesClinical Trials (1)
NCT05105243Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers
Phase 1CVN058
SchizophreniaClinical Trials (1)
NCT03669250CVN058 Effect on Mismatch Negativity in Schizophrenics
Phase 1CVN424
HealthyClinical Trials (1)
NCT03657030Study of CVN424 in Healthy Subjects
Phase 1CVN424
Parkinson's DiseaseClinical Trials (1)
NCT05635461Relative Bioavailability and Food Effect Study of CVN424
Phase 1CVN424 150 mg
Parkinson's DiseaseClinical Trials (1)
NCT06006247Early Parkinson's Disease Monotherapy With CVN424
Phase 2CVN424 Low Dose
Parkinson DiseaseClinical Trials (1)
NCT04191577Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Phase 2CVN424 75 mg
Parkinson DiseaseClinical Trials (1)
NCT06553027To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2015
Portfolio: 1 approved product, 7 clinical trials
Top TAs: Neurology
Portfolio Health
Peak1 (100%)
1 total products